Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Guggenheim Analyst Says

Tempus AI (NASDAQ:TEM - Get Free Report) had its price objective increased by analysts at Guggenheim from $65.00 to $75.00 in a research note issued on Monday,Benzinga reports. The firm currently has a "buy" rating on the stock. Guggenheim's price objective suggests a potential upside of 23.66% from the stock's previous close.

A number of other analysts have also recently commented on TEM. Bank of America increased their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Piper Sandler raised their target price on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. BTIG Research initiated coverage on Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. Needham & Company LLC reissued a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research report on Wednesday, May 7th. Finally, Morgan Stanley upped their price objective on Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $63.67.

Tempus AI Price Performance

TEM traded up $1.47 on Monday, hitting $60.65. 6,389,112 shares of the company were exchanged, compared to its average volume of 7,393,926. The stock's fifty day moving average is $62.23 and its 200-day moving average is $53.69. Tempus AI has a 12 month low of $30.77 and a 12 month high of $91.45. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's quarterly revenue was up 75.4% on a year-over-year basis. As a group, research analysts forecast that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling at Tempus AI

In related news, CAO Ryan M. Bartolucci sold 6,073 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the transaction, the chief accounting officer directly owned 47,799 shares in the company, valued at approximately $3,022,330.77. This represents a 11.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Theodore Leonsis sold 205,847 shares of Tempus AI stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the completion of the sale, the director owned 15,511 shares of the company's stock, valued at $1,049,474.26. This trade represents a 92.99% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 607,522 shares of company stock worth $41,300,238 in the last 90 days. Company insiders own 27.60% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Operose Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at approximately $25,000. Cherry Tree Wealth Management LLC acquired a new position in Tempus AI in the 1st quarter valued at $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI during the 1st quarter valued at $33,000. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI during the 4th quarter worth $34,000. Finally, Prestige Wealth Management Group LLC increased its position in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the period. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.